Opinion Article by Dr. Paul Deffley, Chief Medical Officer, Alcidion.Recent research from Newsweek and Statista, which ranked the world’s top 'smart hospitals', placed its first NHS trust at position 72 on the list.
The new tool improves on existing risk assessment tools for heart failure by harnessing the power of machine learning (ML) and artificial intelligence (AI) to determine patient-specific risks of developing unfavorable outcomes with heart failure.
Challenges include questions about data privacy and algorithmic bias, how we can make sure that AI tools are subject to robust validation and testing processes, and how to make sure they are used safely in a clinical setting.
The study challenges perceptions that chatbots are impartial and provides insight into how using conversational search systems could widen the public divide on hot-button issues and leave people vulnerable to manipulation.
The trust, which employs 14,000 people across two acute hospitals, 13 community hospitals and a range of community, primary care and mental health services, is planning to go-live with the new recruitment, applicant management, and reporting software in May.
AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment.
The association has seen substantial growth in recent years, with membership also including suppliers of health IT, AI and care equipment such as patient monitors. AXREM helps to facilitate cross industry dialogue on key issues affecting the sector.
Combined with additional algorithms, the predictive model, described in the current issue of the journal Nature Biotechnology,